Dashboard
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 4.57%
- Poor long term growth as Net Sales has grown by an annual rate of 8.26% and Operating profit at 17.61% over the last 5 years
- Low ability to service debt as the company has a high Debt to EBITDA ratio of 8.26 times
- PAT(Latest six months) Higher at Rs 0.03 cr
- NET SALES(Q) Highest at Rs 15.19 cr
- PBDIT(Q) Highest at Rs 0.48 cr.
With ROCE of 5.1, it has a Attractive valuation with a 1.2 Enterprise value to Capital Employed
Majority shareholders : Non Institution
Market Beating performance in long term as well as near term
Stock DNA
Garments & Apparels
INR 9 Cr (Micro Cap)
288.00
24
0.00%
1.64
0.52%
1.49
Total Returns (Price + Dividend) 
Nutech Global for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Nutech Global Sees Unprecedented Buying Interest Amid Upper Circuit Scenario
Nutech Global Ltd, a key player in the Garments & Apparels sector, is currently experiencing extraordinary buying interest, with the stock hitting the upper circuit and an exclusive queue of buy orders dominating the market. This rare phenomenon signals a potential multi-day circuit scenario, reflecting strong investor enthusiasm despite a flat day’s price movement.
Read More
Nutech Global Sees Unprecedented Buying Interest Amid Upper Circuit Scenario
Nutech Global Ltd, a key player in the Garments & Apparels sector, has attracted extraordinary buying interest, resulting in an upper circuit situation with only buy orders in the queue. This rare market phenomenon signals robust demand and the potential for a multi-day circuit scenario, reflecting strong investor confidence despite mixed broader market trends.
Read More
Nutech Global Surges to Upper Circuit Amid Unprecedented Buying Interest
Nutech Global Ltd, a key player in the Garments & Apparels sector, witnessed extraordinary buying momentum today, hitting the upper circuit with only buy orders in the queue. This rare market phenomenon signals robust investor enthusiasm and the potential for a sustained multi-day circuit scenario, setting the stock apart from broader market trends.
Read More Announcements 
Announcement under Regulation 30 (LODR)-Newspaper Publication
12-Nov-2025 | Source : BSENewspaper Publication.
Board Meeting Outcome for Board Meeting Outcome For Un-Audited Financial Results For The Quarter And Half Year Ended On 30 September 2025.
10-Nov-2025 | Source : BSEFinancial Results for the quarter and half year ended 30.09.2025
Financial Results For The Quarter And Half Year Ended 30.09.2025
10-Nov-2025 | Source : BSEFinancial Results for the quarter and Half year ended 30.09.2025
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2025
Shareholding Compare (%holding) 
Non Institution
None
Held by 0 Schemes
Held by 0 FIIs
Shyam Sunder Mukhija (19.04%)
Ritu Mukhija (6.84%)
56.61%
Quarterly Results Snapshot (Standalone) - Sep'25 - QoQ
QoQ Growth in quarter ended Sep 2025 is 100.93% vs 0.00% in Jun 2025
QoQ Growth in quarter ended Sep 2025 is 221.43% vs -227.27% in Jun 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is 10.11% vs 1.57% in Sep 2024
Growth in half year ended Sep 2025 is 110.34% vs -141.67% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'24
YoY Growth in nine months ended Dec 2024 is -0.68% vs 2.40% in Dec 2023
YoY Growth in nine months ended Dec 2024 is -66.67% vs -318.18% in Dec 2023
Annual Results Snapshot (Standalone) - Mar'25
YoY Growth in year ended Mar 2025 is -3.78% vs 4.74% in Mar 2024
YoY Growth in year ended Mar 2025 is -262.50% vs -172.73% in Mar 2024






